The Efficacy and Safety of Beta-blockers Drugs in Adults With Spinal Hemangioma

Clinical trial NCT05106179 · UNKNOWN

Trial details

NCT number: NCT05106179
Sponsor: Center for Vascular Pathology, Moscow
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Spinal Tumor Spinal Hemangioma Beta Blocker Toxicity

Start date: 2021-12-01
Primary completion: 2022-12-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.